Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)

Novartis today announced positive top-line results from the pre-specified interim analysis of the Phase III APPLAUSE-IgAN study (NCT04578834) at 9 months1. Iptacopan, an investigational factor B inhibitor targeting the alternative complement pathway, demonstrated superiority versus placebo in proteinuria (protein in…

Read MoreNovartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)

Allergan Aesthetics and Girls Inc. Partner to Speed the Entry of Young Women into Positions of Leadership in the STEM Field

Today Allergan Aesthetics, an AbbVie company, announces its fifth year of partnership with Girls Inc., this year supporting Project Accelerate, a program addressing inequality in the workplace that aims to accelerate young women’s trajectories through college and career entry. The Allergan…

Read MoreAllergan Aesthetics and Girls Inc. Partner to Speed the Entry of Young Women into Positions of Leadership in the STEM Field

Aetna donates $70,000 to Ronald McDonald House Charities of Kansas City for critical expansion project

Aetna Better Health of Kansas, a CVS Health® company (NYSE: CVS), announced that Aetna® donated $70,000 to the Ronald McDonald House Charities of Kansas City. The significant contribution will facilitate the renovation and expansion of the family room within Children’s Mercy…

Read MoreAetna donates $70,000 to Ronald McDonald House Charities of Kansas City for critical expansion project

From cold chain to chemical vaults: The critical role of specialized handling in medical product and pharmaceutical supply chain

Specialized handling capabilities within the healthcare supply chain, such as cold storage and chemical vaults, are essential to safeguarding the potency and efficacy of life-saving medicine and medical products. Demand for specialized handling capabilities is increasing, driven by advances in…

Read MoreFrom cold chain to chemical vaults: The critical role of specialized handling in medical product and pharmaceutical supply chain

SetPoint Medical Announces Publication of Data for Neuroimmune Modulation to Treat Crohn’s Disease in Journal of Crohn’s and Colitis

SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, today announced the publication of data from a multicenter European clinical trial evaluating the safety and efficacy of neuroimmune modulation in patients with treatment-refractory Crohn’s disease in…

Read MoreSetPoint Medical Announces Publication of Data for Neuroimmune Modulation to Treat Crohn’s Disease in Journal of Crohn’s and Colitis

Integral Launches Privacy Workbench to Revolutionize Data Quality and Certification

Integral, an innovator in safeguarding privacy and maximizing data quality, today announced the launch of its privacy analytics suite, Privacy Workbench. The privacy analytics suite adds to defense-in-depth security strategies while allowing fast and carefully controlled review processes for companies…

Read MoreIntegral Launches Privacy Workbench to Revolutionize Data Quality and Certification

Thrive Health Places No. 21 on The Globe and Mail’s Fifth-Annual Ranking of Canada’s Top Growing Companies

Thrive Health is pleased to announce it placed No. 21 on the 2023 Report on Business ranking of Canada’s Top Growing Companies. In total, 425 companies earned a spot on this year’s ranking. Thrive Health, a leader in Canadian healthcare…

Read MoreThrive Health Places No. 21 on The Globe and Mail’s Fifth-Annual Ranking of Canada’s Top Growing Companies

FineHeart Obtains Czech Health Authority Approval to Commence First in Human Clinical Study

FineHeart S.A, a medical device company developing innovative devices for cardiology announced today that it has received authorization from the SUKL (the Czech Republic State Institute for the Control of Medicinal Products) to carry out “A prospective, single arm, single…

Read MoreFineHeart Obtains Czech Health Authority Approval to Commence First in Human Clinical Study

Lokavant Announces $8M Strategic Investment from Mitsui & Co. to Expand AI and Predictive Clinical Trial Intelligence into Asia-Pacific

Lokavant, the clinical trial intelligence platform company, today announces an $8 million strategic investment from global business titan Mitsui & Co. Ltd. to expand its AI-optimized platform across the Asia-Pacific (APAC) region. One of Lokavant’s earliest customers, CMIC Group, is the…

Read MoreLokavant Announces $8M Strategic Investment from Mitsui & Co. to Expand AI and Predictive Clinical Trial Intelligence into Asia-Pacific